The primary endpoints were maximum plasma concentration ( Cmax ) of linagliptin and metformin , area under the plasma concentration time curve from 0 to 72 hours ( AUC0-72 ) for linagliptin , and from 0 to infinity ( AUC0-inf ) for metformin .